Skip to main content

Table 6 Operating characteristics for detecting differences in the primary endpoint

From: A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trial

Total N

(intervention + control)

Ratio

Type 1 error

Proportion of patients achieving a reduction in ICS or OCS

Power

Control

Intervention

Difference

400 (320 + 80)

4:1

0.05

10%

26%

16%

83%

300 (240 + 60)

4:1

0.05

10%

29%

19%

83%

200 (160 + 40)

4:1

0.05

10%

34%

24%

83%

  1. Assumes a 20% drop out rate
  2. ICS inhaled corticosteroid, OCS oral corticosteroid